- Home
- QURE vs TTGT Comparison
QURE vs TTGT Comparison
Compare QURE & TTGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- TTGT
- Stock Information
- Founded
- QURE 1998
- TTGT 1999
- Country
- QURE Netherlands
- TTGT United States
- Employees
- QURE N/A
- TTGT N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- TTGT Telecommunications Equipment
- Sector
- QURE Health Care
- TTGT Telecommunications
- Exchange
- QURE Nasdaq
- TTGT Nasdaq
- Market Cap
- QURE 725.4M
- TTGT 598.8M
- IPO Year
- QURE 2007
- TTGT 2007
- Fundamental
- Price
- QURE $17.27
- TTGT $7.17
- Analyst Decision
- QURE Strong Buy
- TTGT Strong Buy
- Analyst Count
- QURE 10
- TTGT 6
- Target Price
- QURE $37.20
- TTGT $23.50
- AVG Volume (30 Days)
- QURE 1.4M
- TTGT 343.5K
- Earning Date
- QURE 07-31-2025
- TTGT 06-17-2025
- Dividend Yield
- QURE N/A
- TTGT N/A
- EPS Growth
- QURE N/A
- TTGT N/A
- EPS
- QURE N/A
- TTGT N/A
- Revenue
- QURE $20,201,000.00
- TTGT $284,897,000.00
- Revenue This Year
- QURE $27.16
- TTGT $79.55
- Revenue Next Year
- QURE $248.21
- TTGT N/A
- P/E Ratio
- QURE N/A
- TTGT N/A
- Revenue Growth
- QURE 6.30
- TTGT 13.01
- 52 Week Low
- QURE $3.73
- TTGT $6.80
- 52 Week High
- QURE $19.18
- TTGT $33.08
- Technical
- Relative Strength Index (RSI)
- QURE 67.53
- TTGT 41.81
- Support Level
- QURE $14.75
- TTGT $6.80
- Resistance Level
- QURE $15.50
- TTGT $8.80
- Average True Range (ATR)
- QURE 1.07
- TTGT 0.80
- MACD
- QURE 0.16
- TTGT 0.03
- Stochastic Oscillator
- QURE 93.40
- TTGT 18.50
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About TTGT TechTarget Inc.
TechTarget Inc is engaged in the business-to-business (B2B) accelerator, informing and influencing technology buyers and sellers. Through its B2B first-party data and an end-to-end portfolio of data-driven solutions, it services the full B2B product lifecycle for customers from, messaging, and content development to in-market activation via brand, demand generation, purchase intent data, and sales enablement from R&D to ROI.